Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
Net Margin
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | CN |
| Market Cap | 39.1B HKD |
| Net Margin |
-37%
|
| Country | US |
| Market Cap | 299.1B USD |
| Net Margin |
11%
|
| Country | US |
| Market Cap | 163.6B USD |
| Net Margin |
13%
|
| Country | US |
| Market Cap | 124.8B USD |
| Net Margin |
39%
|
| Country | US |
| Market Cap | 110.5B USD |
| Net Margin |
29%
|
| Country | AU |
| Market Cap | 139.6B AUD |
| Net Margin |
17%
|
| Country | US |
| Market Cap | 80.6B USD |
| Net Margin |
2%
|
| Country | US |
| Market Cap | 57.8B USD |
| Net Margin |
-116%
|
| Country | US |
| Market Cap | 43.1B USD |
| Net Margin |
-33%
|
| Country | US |
| Market Cap | 32.8B USD |
| Net Margin |
12%
|
| Country | KR |
| Market Cap | 39.6T KRW |
| Net Margin |
17%
|
Profitability Report
View the profitability report to see the full profitability analysis for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Sichuan Kelun-Biotech Biopharmaceutical Co Ltd's most recent financial statements, the company has Net Margin of -37.3%.
You don't have any saved screeners yet
